The standard treatment for gastric cancer is surgical resection and perioperative adjuvant
treatment. Multidisciplinary treatment for gastric cancer leads to nutritional and inflammatory …

Various blood cell ratios exist which seem to have an impact on prognosis for resected
gastric cancer patients. The aim of this systematic review was to investigate the prognostic …

Cancer treatment remains a significant challenge for the medical community, and improved
therapies are necessary to treat cancer and its associated complications. Current anticancer …

Background Gastric cancer (GC) patients with advanced age and/or multiple morbidities
have limited expected survival and may not benefit from extended lymph node resection …

Abstract Background and Objective Neoadjuvant chemotherapy (NACT) followed by radical
surgery represents a treatment option for patients with advanced gastric cancer (GC). This …

Background Postoperative chemotherapy (CMT) or chemoradiotherapy (CRT) is commonly
recommended for gastric cancer (GC) patients in order to improve survival. However, some …

Introduction Multivisceral resection (MVR) is potentially curative for selected gastric cancer
patients, supposedly at the cost of increased complications. However, current data …

Background The fecal occult blood (FOB) test is one of the primary screening methods for
colorectal cancer (CRC). In this study, we aimed to investigate the effect of the …

Aim Systemic inflammation and nutritional status are associated with clinical outcomes of
cancer patients. We investigated the prognostic value of preoperative C‐reactive protein to …

Background Adjuvant chemotherapy offers survival benefit to patients with gastric cancer.
Only 50–65% of patients who undergo neoadjuvant chemotherapy and gastrectomy are …